Literature DB >> 16269056

Hepatoblastoma in a child with progressive familial intrahepatic cholestasis.

A Richter1, E Grabhorn, A Schulz, H J Schaefer, M Burdelski, R Ganschow.   

Abstract

End-stage liver cirrhosis because of metabolic or infectious diseases predisposes to hepatic malignancies like hepatocellular carcinoma. We report the first case of hepatoblastoma incidentally detected in the explanted liver of a 2-yr-old child undergoing liver transplantation for cirrhosis because of progressive familial intrahepatic cholestasis (PFIC). The diagnosis was difficult to obtain. The hepatoblastoma was not seen on ultrasound examination of the cirrhotic liver. As we could confirm retrospectively, alpha fetoprotein (AFP) was found elevated prior to transplantation. Two years after successful transplantation, there are no signs of malignancy detectable by clinical and radiological methods. We conclude from this case that PFIC may induce hepatoblastoma and that children with liver cirrhosis should undergo routine screening of serum AFP concentration.

Entities:  

Mesh:

Year:  2005        PMID: 16269056     DOI: 10.1111/j.1399-3046.2005.00380.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  3 in total

Review 1.  Liver transplantation and the management of progressive familial intrahepatic cholestasis in children.

Authors:  Ashley Mehl; Humberto Bohorquez; Maria-Stella Serrano; Gretchen Galliano; Trevor W Reichman
Journal:  World J Transplant       Date:  2016-06-24

2.  Clinical and ABCB11 profiles in Korean infants with progressive familial intrahepatic cholestasis.

Authors:  Ji Sook Park; Jae Sung Ko; Jeong Kee Seo; Jin Soo Moon; Sung Sup Park
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

3.  Novel ATP8B1 mutation in an adult male with progressive familial intrahepatic cholestasis.

Authors:  Bao-Cheng Deng; Sa Lv; Wei Cui; Rui Zhao; Xu Lu; Jian Wu; Pei Liu
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.